[Phosphocalcic anomalies and bone fragility keys for the general practitioner]

General practitioners often encounter patients with unexplained bone fragility. Established knowledge shows that osteoporosis is a common cause, but many cases remain unexplained. This gap motivated a deeper investigation into secondary causes. No prior work had resolved how to systematically identify these causes in primary care settings. Prior research has shown that abnormal calcium and phosphate levels may indicate underlying conditions. However, the specific relationship between these anomalies and bone fragility remains unclear. That uncertainty drove the need for a structured approach to diagnosis. This paper's contribution is to provide a framework for identifying rare and frequent causes of bone fragility.

The aim of this study is to guide general practitioners in recognizing secondary causes of bone fragility. The specific problem is the lack of a standardized approach to interpreting calcium and phosphate anomalies. This uncertainty can lead to missed diagnoses of rare diseases. The motivation is to improve patient outcomes through early detection. The paper focuses on distinguishing frequent from rare causes of these anomalies. It also addresses iatrogenic causes that may be overlooked. The goal is to provide a practical framework for clinical decision-making. This approach helps avoid misdiagnosis and unnecessary treatments.

The study uses clinical case presentations to illustrate diagnostic approaches. It analyzes abnormal calcium, phosphate, and vitamin D levels in patients. The approach involves correlating laboratory results with clinical symptoms. No specific experimental design is used; instead, case-based reasoning is emphasized. The method includes identifying frequent causes such as nutritional deficiencies. It also covers less common iatrogenic causes like drug-induced hypophosphatemia. Genetic causes are discussed as rare but significant contributors. The framework is designed to be adaptable to primary care settings.

The strongest finding is that abnormal calcium and phosphate levels can indicate rare diseases. Genetic causes of these anomalies are more impactful than expected. Vitamin D deficiency is a common but often overlooked cause. Iatrogenic causes such as drug-induced hypophosphatemia are frequently misdiagnosed. The study highlights the importance of a multidisciplinary approach. Clinical cases demonstrate the variability in patient presentations. The framework helps distinguish between frequent and rare causes. These findings suggest a need for improved diagnostic protocols in general practice.

The authors propose that abnormal calcium and phosphate levels should prompt a thorough evaluation. They suggest that rare genetic causes may be underdiagnosed in primary care. The study emphasizes the importance of a multidisciplinary approach. It does not claim that all cases of bone fragility are due to rare diseases. The framework may help improve diagnostic accuracy. The authors do not suggest that all iatrogenic causes are preventable. They propose that general practitioners should consider rare diseases in their differential diagnosis. These conclusions are based on the clinical cases presented.